Additive Effects of 5-HTTLPR (Serotonin Transporter) and Tryptophan Hydroxylase 2 G-703T Gene Polymorphisms on the Clinical Response to Citalopram among Children and Adolescents with Depression and Anxiety Disorders

Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy

(2011) Stefano Porcelli et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Pharmacogenetics of Antidepressants

(2011) Concetta Crisafulli et al.   Frontiers in Pharmacology

Description and Validation of a Dynamical Systems Model of Presynaptic Serotonin Function: Genetic Variation, Brain Activation and Impulsivity

(2010) Scott F. Stoltenberg et al.   BEHAVIOR GENETICS

Treatment of adolescent depression: what we have come to know

(2009) Benedetto Vitiello   DEPRESSION AND ANXIETY

Serotonin transporter promoter region polymorphisms do not influence treatment response to escitalopram in patients with major depression

(2009) Eduard Maron et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Effectiveness and tolerability of citalopram for the treatment of depression and anxiety disorders in children and adolescents: an open-label study

(2009) Shella Schirman et al.   JOURNAL OF NEURAL TRANSMISSION

Remission and Recovery in the Treatment for Adolescents With Depression Study (TADS): Acute and Long-Term Outcomes

(2009) Betsy D. Kennard et al.   JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

SLC6A4 variation and citalopram response

(2008) D.A. Mrazek et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS

Additive effects of serotonin transporter and tryptophan hydroxylase-2 gene variation on neural correlates of affective processing

(2008) Turhan Canli et al.   BIOLOGICAL PSYCHOLOGY

Cognitive Behavioral Therapy, Sertraline, or a Combination in Childhood Anxiety

(2008) John T. Walkup et al.   NEW ENGLAND JOURNAL OF MEDICINE